There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Our understanding of the global impact and cost of human toxocariasis is poor because
there is insufficient clinical awareness and no clear repository for the efficacy
of clinical, laboratory and treatment interventions. Uniform clinical and laboratory
investigative approaches maximize disease diagnosis. International collaboration is
required to develop web-based, professional educational support, surveillance questionnaires
and standardized serodiagnostic criteria. Determining clinical benefits and treatment
outcomes using less crossreactive antigens will enhance clinical and treatment interventions.
Increased liaison will identify realistic occurrence and prevalence data and cost
benefits of intervention. Web-based centres of excellence and repositories of current
knowledge, which augment current veterinary and public health educational sites, should
be supported. Expected outcomes should be capable of addressing the clinical and financial
burdens of this treatable disease.